Riskpilot← Back to searchSign inGet full accessMEDTECH CONSULTING SWEDEN AB
ABActiveOrg 5565991014Prästhagsvägen 25 BEngineering activities and related technical consultancy · NACE 7112Est. 20000 employees
Revenue 2024
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
—
0 employees
| Revenue | — | — |
| EBITDA | SEK 0 | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 0 | — |
Legal name
MEDTECH CONSULTING SWEDEN AB
Org number
5565991014
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
8 november 2000
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva konsultationer inom medicinsk teknik och flygteknik, handel med och förvaltning av värdepapper och fast egendom samt därmed förenlig verksamhet.
Address
Prästhagsvägen 25 B
Phone
+46705292507
Email
bjarne@medtechconsulting.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 20 | 5 | 4 | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −7 | −8 | −3 | 0 | 0 |
| Depreciation & amort. | −1 | −0 | −0 | — | — |
| EBIT | −8 | −8 | −3 | 0 | 0 |
| Net financials | — | — | — | — | — |
| Profit before tax | −8 | −8 | −3 | 0 | 0 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | −8 | −8 | −3 | — | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 75 | 67 | 64 | — | — |
| Equity | 64 | 57 | 54 | — | — |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 10 | 10 | 10 | — | — |
| Total debt | 10 | 10 | 10 | — | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
AM | Audit | 2020 – 2022 |
GR Auditor Substitute | Auditor Substitute | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDTECH CONSULTING SWEDEN AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne Mikael Brandstam | Audit | 0 companies |
| Gisela René Gribe | Auditor Substitute | 0 companies |
| Olof Bjarne Lundholm | Board of Directors | 0 companies |